Ridwan Shabsigh, MDRidwan Shabsigh, MD
Department of Urology
Columbia-Presbyterian Medical Center
The Atchley Pavilion, 11th floor
161 Fort Washington Avenue
New York, NY 10032 USA
Email: RShabsigh@urology.cpmc.columbia.edu 

Columbia-Presbyterian Hospital Columbia-Presbyterian Eastside 
The Atchley Pavilion, Room 1119 16 East 60th Street 
161 Fort Washington Avenue New York, NY 10022 USA
Tel: +1-212-305-0123 / Fax: +1-212-305-0126
Email: RS66@Columbia.edu 

view presentation | view presentation transcript | view abstract | watch interview video | view interview transcriptprint this page

Bibliography:

  1. Original papers, (peer review):
    1. F.B. Scott, I.J. Fishman, & R. Shabsigh: The impact of the artificial urinary sphincter on the upper urinary tracts in the neurogenic bladder. J. Urol., 136:636, 1986.
    2. I.J. Fishman, R. Shabsigh & A.L. Kaplan: Lower urinary tract dysfunction after radical hysterectomy for carcinoma of the cervix. Urol., 28:462, 1986.
    3. R. Shabsigh*, I.J. Fishman & M. Krebs: The use of transrectal longitudinal real-time ultrasonography in urodynamics. J. Urol., 138:1416, 1987.
    4. R. Shabsigh*, I.J. Fishman & M. Krebs: Combined transrectal ultrasonography and urodynamics in the evaluation of detrusor sphincter dyssynergia. Br. J. Urol., 62: 326, 1988.
    5. R. M. Decter, D.R. Roth, I.J. Fishman, R. Shabsigh, F.B. Scott & E.T. Gonzales: The use of AS-800 in extrophy-epispadias. J. Urol., 140: 1202, 1988.
    6. R. Shabsigh*, I.J. Fishman & F.B. Scott: Evaluation of erectile impotence. Urol., 32: 83, 1988.
    7. M.J. Gleeson, R. Shabsigh & D.P. Griffith: Outcome of ESWL in patients with multiple renal calculi based on stone burden and location. J. Endourol., 2: 145, 1988.
    8. I.J. Fishman, R. Shabsigh & F.B. Scott: Experience with the artificial urinary sphincter AS-800 in 148 patients. J. Urol., 141: 307, 1989.
    9. M.J. Gleeson, R. Shabsigh & D.P. Griffith: ESWL monotherapy of renal calculi substratified by site, size and multiplicity. Scan. J. Nephrol. & Urol., supplementum 122: 11, 1989.
    10. R. Shabsigh*, S. Lerner, I.J. Fishman & D. Kadmon: The role of transrectal ultrasonography in the diagnosis and management of prostatic and seminal vesicle cysts. J. Urol., 141: 1206, 1989.
    11. R. Shabsigh*, D. Kadmon, I.J. Fishman: Ultrasonographically guided transperineal prostate biopsy in patients with suspicious glands and previously negative digitally guided biopsies. J. Endourol., 3: 185, 1989.
    12. R. Shabsigh*, I.J. Fishman, E.T. Quesada & C. Seale-Hawkins: Evaluation of vasculogenic erectile impotence using duplex ultrasonography. J. Urol., 142: 1469, 1989.
    13. R. Shabsigh*, I.J. Fishman, Y. Shotland, I. Karacan & J.K. Dunn: Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J. Urol., 143: 924, 1990.
    14. R. Shabsigh*, S. Lerner, I.J. Fishman & D. Kadmon: The role of transrectal ultrasonography in the diagnosis and management of prostatic and seminal vesicle cysts. Abstracts International, 1990.
    15. R. Shabsigh*, I.J. Fishman & C. Schum: The role of cigarette smoking and other vascular risk factors in the pathogenesis of impotence. Urol., 38: 227, 1991.
    16. R. Shabsigh*, I.J. Fishman, B.D. Toombs & M. Skolkin: Venous leaks: anatomic and physiologic observations. J. Urol., 146: 1234, 1991.
    17. R. Shabsigh*: Sports-trauma-related impotence; treatment with penile revascularization. med. Asp. Hum. Sex., March: 56, 1991.
    18. S.A. Kaplan, R. Shabsigh, K.A. Soldo & C.A. Olsson: Prostatic and periprostatic interstitial temperature measurements during transrectal thermal therapy (local intracavitary microwave hyperthermia). J. Urol., 147: 1562, 1992.
    19. A.E. Te, M. Colombel, H.P. Koo, S.A. Kaplan, R. Buttyan, C.A. Olsson & R. Shabsigh*: Castration-induced apoptosis in the rat penis. Surg. Forum, 43: 724, 1992.
    20. S. A. Kaplan, R. Shabsigh, K.A. Soldo, J.G. Blaivas & C.A. Olsson: Transrectal hyperthermia in the management of men with prostatism: an algorithm for therapy. Br. J. Urol., 72: 195-200, 1993.
    21. R. Shabsigh*: medication-related impotence. Contemp. Urol., 5:51, 1993.
    22. A.E. Te, R.P. Santarosa, H.P. Koo, S.A. Kaplan, C.A. Olsson, R. Buttyan & R. Shabsigh*: Neurotrophins in the diabetic rat penis, a long-term study. Surg. Forum, 44: 758, 1993.
    23. H.P. Koo, R.P. Santarosa, R. Buttyan, R.Shabsigh, C.A. Olsson & S. Kaplan: Early molecular changes associated with streptozotocin induced diabetic bladder hypertrophy in the rat. Urol. Res. 21: 375-381, 1994.
    24. A.E. Te, R.P. Santarosa, H.P. Koo, R. Buttyan, L. Greene, S.A. Kaplan, C.A. Olsson & R. Shabsigh*: Neurotrophic factors in the rat penis. J. Urol., 152: 2167-2172, 1994.
    25. A. J. Kirsch, D.T. Chang, M.I. Miller, J.P. Connor, T.W. Hensle and R. Shabsigh*: Laser-welding versus suturing in tunica vaginalis and venous patch graft corporoplasty. J. Urol. 154: 854-857, 1995.
    26. A. J. Kirsch, M.I. Miller, T.W. Hensle D.T.Chang, R. Shabsigh, C.A. Olsson, & , J.P. Connor: Laser-tissue soldering in urinary tract reconstruction: First human experience. Urol. 46: 261-6, 1995.
    27. E. K. Seaman, I. S. Sawczuk, M. Fatal, C. A. Olsson & R. Shabsigh*: Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum. Urol., 47: 353-355, 1996.
    28. H. Padma-Nathan, W.J.G. Hellstrom, F.E. Kaiser, R.F. Labasky, T.F. Lue, W.E. Nolten, P.C. Norwood, C.A. Peterson, R. Shabsigh, P.Y. Tam, V.A. Place, &N. Gesundheit: Treatment of erectile dysfunction in men by transurethral Alprostadil. N. Engl. J. Med., 336: 1-7, 1997.
    29. L. T. Klein, M. I. Miller, R. Buttyan, A. Raffo, M. Burchardt, G. deVries, C. A. Olsson & R. Shabsigh*: Apoptosis in the rat penis after denervation. J. Urol., 158: 626-630, 1997.
    30. R. Shabsigh*: The role of testosterone in the cavernous tissue and its neural supply. World J. Urol., 15: 21-26, 1997.
    31. R. Shabsigh*, L. Klein, S. Seidman, S.A. Kaplan, Lerhoff, & J. Ritter: High incidence of depressive symptoms is associated with erectile dysfunction. Urol. 52: 848-852, 1998.
    32. R.A. Constabile, M. Spivak, I.J. Fishman, F.E. Govier, W.J.G. Hellstrom, R. Shabsigh, K. Nemo, J. Rapport, P. Tam, K. Weldon, & N. Gesundheit: Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J. Urol., 160: 1325-8, 1998.
    33. R. Shabsigh*, J. Raymond, Carl A. Olsson, K. O’Toole, & R. Buttyan: Androgen induction of DNA synthesis in the rat penis. Urol. 52: 723-8, 1998.
    34. S.A. Kaplan, R.B. Reis, I.J. Kohn, R. Shabsigh, & A.E. Te: Combination therapy utilizing oral alpha blockers and intracavernosal injections in men with erectile dysfunction. Urol. 52: 739-743, 1998.
    35. M. Burchard, T. Burchardt, M.-W. Chen, A. Shabsigh, A. de la Taille, R. Buttyan, & R. Shabsigh*: Expression of messenger RNA splice variants for VEGF in the adult rat and human penis. Biol. Repr., 60: 398-404, 1999.
    36. T. Burchard, M. Burchardt, M.-W. Chen, R. Buttyan, A. de la Taille, A. Shabsigh, & R. Shabsigh*: Expression of VEGF splice variants 144/145 and 205/206 in the adult male tissue. IUBMB Life, 48: 405-8, 1999. 
    37. R. Shabsigh*: Efficacy of Sildenafil citrate (VIAGRA) is not affected by aetiology of erectile dysfunction. Int J Clin Pract Suppl 102: 19-20, 1999. 
    38. R. Rosen, I. Goldstein, J. Heiman, S. Korenman, M. Lakin, T. Lue, D.K. Montague, H. Padma-Nathan, R. Sadovsky, R.T. Segraves, R. Shabsigh: The process of care model for evaluation and treatment of erectile dysfunction. IJIR, 11: 59-74, 1999.
    39. SN Seidman, R. Shabsigh & SP Roose: Phamacologic treatments of sexual dysfunction. Psych Cl N Am: Annual of Drug Therapy, 6: 21-33, 1999.
    40. A. Shabsigh, N. Tanji, V. D’Agati, T. Burchardt, M. Burchardt, O. Hayek, R. Shabsigh*, & R. Buttyan: Vascular anatomy of the rat ventral prostate. The Anat Rec, 256: 403-411, 1999.
    41. A. Shabsigh, R. Buttyan, T. Burchardt, O. Hayek, V. D’Agati, C. Olsson, & R. Shabsigh*: The Microvascular Architecture of the Rat Vagina Revealed by Image Analysis of Vascular Corrosion Casts. IJIR, 11: S23-S30, 1999.
    42. R. Shabsigh*, A. Shabsigh, M. Burchardt, T. Burchardt, & J. Karden: Erectile dysfunction and depression: a dynamic association. Sex Dysf. 2: 32-33, 1999.
    43. R. Shabsigh*, H. Padma-Nathan, M. Gittleman, J. McMurray. J. Kaufman J5 & I. Goldstein: Intracavernous alprostadil (EDEX/VIRIDAL) is more efficacious, better tolerated and more preferred than intraurethral alprostadil (MUSE plus ACTIS ): a comparative, randomized, cross-over, multi-center study. Urol., 55: 109-113, 2000.
    44. J. Berman, A. Burnett, R. Basson, R. Shabsigh, et al: Report on the international consensus development conference on female sexual dysfunction: definitions & classifications. J. Urol., 163: 888-893, 2000.
    45. R. Shabsigh*: Erectile dysfunction and depressive symptoms: an intricate association. Contem. Urol., CME suppl, 16-20, 2000.
    46. M. Burchardt, T. Burchardt, j. Kardan, P. Ying Ng, A. Shabsigh, A. de La Taille, O. Hayek, R. Buttyan, & R. Shabsigh*: Diabetes is associated with reduced cavernosal endothelial cells and smooth muscles: study in aged, and diabetic rats. J. Urol., 2000 Nov. 164: 1807-1811.
    47. R. Shabsigh*, H. Padma-Nathan, M. Gittleman, J. McMurray. J. Kaufman J5 & I. Goldstein: Intracavernous Alprostadil (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urol., 55: 477-480, 2000.
    48. M. Burchardt, T. Burchardt, L. Baer, A.J. Kiss, R.V. Pawar, A. Shabsigh, A. DeTaille, O.R. Hayek, & R. Shabsigh: Hypertension is associated with severe erectile dysfunction. J. Urol., 164: 1188-1191, 2000. 
    49. R. Rosen, C. Brown, J. Heiman, S. Leiblum, C. Meston, R. Shabsigh,, D. Ferguson, R. D'Agostino, Jr.: The index of female sexual function (FSFI) Ó: A multidimensional self-report instrument for the assessment of female sexual function. J. Sex & Mar. Ther., 2000, 26: 191-208.
    50. R. Shabsigh: Recent developments in male sexual dysfunction. Cur Psych Rep., 2: 196-200, 2000.
    51. R. Shabsigh: New advances in the management of Peyronie’s disease. Mediguide to Urology, 2000, 13: 1-5.
    52. E. Fagelman, A. Fagelman & R. Shabsigh*: Efficacy, safety and use of Sildenafil in urologic practice. Urol., 57:1141-1144, 2001.
    53. R. Shabsigh: Prevalence and recent developments in female sexual dysfunction:. Cur Psych Rep., 3:188-194, 2001.
    54. S. Seidman, R. Rosen, M. Menza, S. Roose, & R. Shabsigh: Treatment of erectile dysfunction improves symptoms of depression in men with comorbid depression: results of a placebo controlled clinical trial of sildenafil citrate. AJP, 158: 1623-1630, 2001.
    55. A. Anastasiades, SK. Wilson, & R. Shabsigh: Long term outcomes of inflatable penile implants: reliability, patient satisfaction and complication management. Curr Op Urol., 11: 619-623, 2001.
    56. M. Burchardt, T. Burchardt, L. Baer, A.J. Kiss, R.V. Pawar, A. Shabsigh, A. DeTaille, O.R. Hayek, & R. Shabsigh: Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. IJIR, 2001, 13:276-281.
    57. R. Shabsigh, L. Zakaria, A. Anastasiadis & S. Seidman: Sexual dysfunction and depression: Etiology, Prevalence and Treatment. Curr Urol Rep., 2001, 2:463-467.
    58. Berger R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, Hakim LS, Hellstrom W, Honig S, Levine LA, Lue T, Munarriz R, Montague DK, Mulcahy JJ, Nehra A, Rogers ZR, Rosen R, Seftel AD, Shabsigh, R, & Steers W.: Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res. 2001 Dec; 13 Suppl 5:S39-43.
    59. L. Zakaria, A. Anastasiades, & R. Shabsigh: Common conditions in the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression. Int. Urol & Nephrol, 33: 283-292, 2001.
    60. M. Burchardt, T. Burchardt, L. Baer, A.J. Kiss, R.V. Pawar, A. Shabsigh, A. DeTaille, O.R. Hayek, & R. Shabsigh: Sexual dysfunction is common and overlooked in female patients with hypertension. J. Sex & Mar. Ther., 28: 17-26, 2002. 
    61. R, Shabsigh, A. Anastasiades, MA, Ghafar, and M, Burchardt: Economic aspects of medical erectile dysfunction therapies. Expert Opin Pharmacother, 3 (3), 257-263, 2002.
    62. A. Anastasiades, F. Facherot, MA Ghafar, P. Benedit, M-W. Chen, A. Shabsigh, M. Burchardt, D. Chopin, R. Shabsigh, & R. Buttyan: Hormone refractory human prostate Ca can harbor mutations in the O2 dependant degradation domain of hypoxia inducible factor – alpha 1. J. Cancer Res Cl Onc, 128: 358-362, 2002.
    63. A. Anastasiades, AR Davis, MA, Ghafar, M, Burchardt, & R, Shabsigh: Epidemiology and definition of female sexual disorders. World J Urol, 20:74-78, 2002.
    64. AR Davis, R Shabsigh, S Nowygrod, & C Westhoff: The influence of vaginal bleeding on the sexual behavior of urban Hispanic women and Men. Contraception, 65(5): 351-355, 2002.
    65. HG. Nurnberg, SN. Seidman, AJ. Gelenberg, M. Fava, R. Rosen & R. Shabsigh: Depression, antidepressant therapies, and erectile dysfunction: clinical trials of Sildenafil citrate (Viagra) in treated and untreated patients with depression. Urol., 60 suppl. B: 58-66, 2002.
    66. A G. Anastasiades, A R Davis, & R. Shabsigh: Hormonal factors in female sexual dysfunctions. Curr Op Urol., 12: 505-507,2002.
    67. AG. Anastasiades, L. Salamon, M. Ghafar, M. Burchardt, & R. Shabsigh: Female sexual dysfunction, state of the art. Curr Urol Rep, 3 (6): 484-491, 2002.
    68. R. Shabsigh: Sexual dysfunction and reproductive sciences, advances on several fronts in the new millennium: editorial review. Curr Op Urol., 12: 491-492, 2002.
    69. R. Shabsigh & A. Anastasiades,: Erectile dysfunction. Annual Reviews in Medicine., 2003, 54: 153-168.
    70. S. Stass, A. Anastasiades, H. Fisch, MC Benson, & R. Shabsigh: Urologic aspects of andropause. Urol, 61 (2): 261-266, 2003.
    71. A. Anastasiades, MC Benson, MP Rosenwasser, H. El-Rashidy, MA Ghafar, JM McKiernan, M. Burchardt & R. Shabsigh: Cavernous nerve graft reconstruction during radical prostatectomy and radical cystectomy: safe and technically feasible. Prostate Cancer PD, 6: 56-60, 2003.
    72. Nehra A, Steers WD, Althof SE, Andersson KE, Burnett AL 2nd, Costabile RA, Goldstein I, Kloner RA, Lue TF, Morales A, Rosen RC, Shabsigh R, Siroky MB, King L.: Third International Conference on the Management of Erectile Dysfunction: Linking Pathophysiology and Therapeutic Response. J Urol. 2003 Aug;170(2):S3-S5.
    73. R. Shabsigh*:Hypogonadism and erectile dysfunction: the role of testosterone therapy. Int J Impot Res. 2003 Aug;15 Suppl 4:S9-13.
    74. AG Anastasiades, R. Sachdev, L. Salomon, MA. Ghafar, BC Stisser, R. Shabsigh, & AE Katz: Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol. 2003 Dec;129(12):676-82.
    75. HG. Nurnberg, AJ. Gelenberg, M. Fava, R. Shabsigh, SN. Seidman, R. Rosen: Treatment of Serotonergic Reuptake Inhibitor-Induced Erectile Dysfunction: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. Urol, 2003, suppl, in press.
    76. R. Rosen, SN, Seidman, M. Menza, R. Shabsigh, S. Roose, A. Tseng, D. Orazem, and R. Siegel: QoL, Mood, and Sexual Function: A Path Analytic Model of Treatment Effects in Men With ED and Depressive Symptoms. IJIR, 2003, in press. 
    77. R. Shabsigh*: Urological Perspectives on Andropause. Psych Ann, 2003, in press.
    78. R. Shabsigh*: Understanding ED patient needs and objectives. IJIR., 2003 submitted.
    79. A. Anastasiades, A.R. Davis, I.S. Sawczuk, M. Fleming, M.A. Perelman, & R. Shabsigh: Sexual functioning in kidney cancer patients, data from a national registry. Support Care Cancer. 2003 Nov;11(11):700-6.
    80. A. Anastasiadis, I. Goldstein, L. Lipshultz, H. Padma-Nathan, R. Shabsigh, & P. Lammers: The treatment of male erectile dysfunction with injectable combination of papaverine, phentolamine and prostaglandin E1. IJIR., 2003, submitted.
    81. R Munarriz, R Mittal, KL Billups, FD Borges, SE Dakil, JR Delk, CB Dhabuwala, WP Fitch, MG Fry, LS Hakim, H Hanafy, WT Hitt, JM Kaufman, DT McKnight, JR Ross, BN Secrest, R Shabsigh, D Collins, PE Wherry, SK Wilson, C Wen, P Salimpour, K Min & I Goldstein: The Mentor Alpha-1 penile prosthesis with lock-out valve: a solution to autoinflation. Androl, 2003, submitted.
    82. M. Burchardt, T. Burchardt, AG Anastasiadis, R. Buttyan, A. de La Taille, A. Shabsigh, J. Frank, & R. Shabsigh*: Application of Angiogenic Factors for Therapy of Erectile Dysfunction: Protein and DNA Transfer of VEGF165 into the Rat Penis. IJIR., 2003, submitted.
    83. R. Seyam, T. Abdelbaky, M. Abd El-Gawad, R. Shabsigh, & G. Brock: The role of androgens in sexual function. J. Urol., 2003, submitted.
    84. A. Davis, M. Burchardt, T. Burchardt, L. Baer, & R. Shabsigh,: Sexual dysfunction in women and men attending a hypertension clinic. J. Sex & Mar. Ther., 2003, submitted.
    85. R. Shabsigh, K. Cooper, D. Weiner, A. Davis, N. Husami, & M. Biddleman: Female sexual dysfunction in partners of men with ED. Urol., 2003, submitted.
    86. H. Padma-Nathan, R. Shabsigh, R. Weiss, DD. Michie, & R. Rosen: Efficacy and safety of Alprostadil (Caverject) in Sildenafil (Viagra) failures. IJIR, 2003, submitted.
    87. JC. Trussel, AG. Anastasiadis, & R. Shabsigh: Straitening out Peyronie’s disease. IJIR, 2003 submitted.
    88. CC Carson, R. Shabsigh, S. Segal, A. Murphy, & P. Fredlund: Tadalafil for erectile dysfunction: efficacy, safety and treatment satisfaction. Mayo Cl Proceedings 2003, submitted.
    89. D. Droggin, AG. Anastasiadis, & R. Shabsigh: Antibiotic coating reduces penile prosthesis infection. Urol, 2003, submitted.
    90. R. Shabsigh*, JM Kaufman, C. Steidle, H. Padma-Nathan: Randomized study of AndroGel® (testosterone gel) as adjunctive therapy to Sildenafil in hypogonadal men with erectile dysfunction who do not respond to Sildenafil alone. J. Urol., 2003, submitted. 
    91. CC Carson, R. Shabsigh, S. Segal, A. Murphy, & P. Fredlund: Efficacy, safety and treatment satisfaction of Tadalafil versus placebo in men with erectile dysfunction, evaluated at tertiary care academic centers. Urol 2004, submitted.
  2. Case reports:
    1. I.J. Fishman, R. Shabsigh & F.B. Scott: Urinary undiversion and implantation of the artificial urinary sphincter in a 73 year old male. J. Urol., 138:140-2, 1987.
    2. M. Rosen & R. Shabsigh*: Post TURP ejaculatory duct obstruction. J. Urol., 149: 1555-6, 1993.
    3. R.P. Santarosa, T. Hensle & R. Shabsigh*: Percutaneous transvesical ureteroscopy for the removal of a distal ureteral stone in a reimplanted ureter. Urol: 42: 227-9, 1993.
    4. E. Seaman, M.C. Benson & R. Shabsigh*: Percutaneous management of an Indiana pouch calculus. J. Urol., 151: 690-692, 1994.
  3. Reviews, chapters & editorials:
    1. R. Shabsigh*, M.J. Gleeson & D.P. Griffith: The benefits of stenting on a more or less routine basis. Urol. Cl. N.Am., 15:493-497, 1988.
    2. M.J. Gleeson, R. Shabsigh & D.P. Griffith: Outcome of ESWL in patients with multiple renal calculi based on stone burden and location. Shock Wave Lithotripsy: State of the Art, 1989.
    3. I.J. Fishman & R. Shabsigh: The artificial urinary sphincter AS-800 in the adult. Current Operative Urology, Edited by: E.D. Whitehead. Lippincott, Philadelphia, 1990, Part 3, pp. 116-128.
    4. D.R. Greene, R. Shabsigh & P.T. Scardino: Urologic Ultrasonography. Campbell's Urology, Edited by P.C. Walsh, A.B. Retik, T.A. Stamey & E.D. Vaughn. W.B. Saunders Co., 1992, Vol 1, pp. 342-393.
    5. R. Shabsigh* & J.G. Blaivas: Urinary and sexual dysfunction. In: Cancer of the colon, rectum and anus, Edited by: A.M. Cohen, S.J. Winawer, M.A. Friedman & L.L. Gunderson, McGraw-Hill Inc., New York, 1994, pp 787-795.
    6. R. Shabsigh* & J.G. Blaivas: The bladder after abdomino-perineal excision of the rectum. Clinical Urology. Edited by: Hugh Whitfield, Bill Hendry, R. S. Kirby & John Duckett. Blackwell Scientific Publishers, London, 1995.
    7. I.S. Sawczuk, R. Shabsigh, H. Nagler & C.A. Olsson: The Genitourinary system. Columbia-Presbyterian Medical Book, 1994.
    8. R. Shabsigh*: Editorial: Impotence on the rise as a urologic subspecialty. J. Urol., 155: 924-925, 1996.
    9. R. Shabsigh*: Editorial: Penile prosthesis at the end of the millenium. J. Urol., 159: 819, 1998.
    10. H. Padma-Nathan, & R. Shabsigh: Sildenafil Citrate (Viagra): a Review. American Urological Association Update Series, Vol 58, lesson 35: 274-280, 1999.
    11. R. Shabsigh*: Economical Aspects of erectile dysfunction. Ch 2 in: Erectile Dysfunction, 1st International Consultation on ED co-sponsored by the World Health Organization (WHO), International Society of Impotence Research (ISIR) and Societe Internationale d’Urologie (SIU), Edited by A. Jardin, G. Wagner, S. Khouri, & F. Giuliano,H. Padma-Nathan, & R. Rosen, Health Publications Ltd 2000.
    12. R. Shabsigh,: Strategic planning in research and development is needed in female sexual dysfunction. J. Sex & Mar. Ther., 27: 209-210, 2001.
    13. R. Shabsigh*: Socioeconomic considerations in erectile dysfunction treatment. Urol. Cl. N.Am., 28: 417-422, 2001.
    14. R. Shabsigh*: Editor-in-chief: Sildenafil Viagra Three Years Later, A worldwide review of clinical articles from the scientific literature, a CME book sponsored by Columbia University Center for Continuing Medical Education. PharmaLibri Publishers Inc, Montreal, Canada, 2001.
    15. R. Shabsigh*: Intra-Corporal Therapy. Male Sexual Function: a Guide to Clinical Management, Edited by J.J. Mulcahy, Humana Press Inc, 2001, Totowa, New Jersey, Ch. 13, pp 245-251.
    16. R. Shabsigh*: Female sexual dysfunction. New chapter in Campbell’s Urology, edited by PC Walsh, Saunders, Philadelphia, Pennsylvania, 2002, Ch 48, pp 1710-1733.
    17. R. Shabsigh*: Urological perspectives of andropause. Psychiatric Annals, 2003, in press.
    18. R. Shabsigh*: Back to Great Sex, Overcome ED and Reclaim Lost Intimacy. Kensington Books, New York, 2002. (patient education book, 226 pages).
    19. A. Anastasiadis, R. Shabsigh: Sexual dysfunction. Chapter In: Principles of Gender Specific Medicine, edited by: Marianne J. Legato, Elsevier Science, San Diego, California, 2003, in press.
  4. Abstracts:
    1. I.J. Fishman, R. Shabsigh: Effects of botulinum toxin on the detrusor muscle of the rabbit for possible treatment neurogenic detrusor hyperreflexia. Canadian Urological Association Annual Meeting, Montreal, Canada, 1985.
    2. R. Shabsigh*, I.J. Fishman & F.B. Scott: Clinical experience with the artificial urinary sphincter AS-792/1 & AS-800 in 546 patients. German Urological Congress Annual Mtg., Cuxhaven, Germany, 1985. 
    3. R. Shabsigh*, I.J. Fishman & F.B. Scott: Clinical experience with the inflatable penile prosthesis IPP-700 in 191 patients. German Urological Congress Annual Meeting, Cuxhaven, Germany, 1985.
    4. I.J. Fishman, R. Shabsigh & A.L. Kaplan: Lower urinary tract dysfunction after radical hysterectomy for carcinoma of the cervix. J. Urol., 133: 306A, Abstract A#770, 1985.
    5. R. Shabsigh*, I.J. Fishman & M. Krebs: The use of transrectal longitudinal real-time ultrasonography in urodynamics. J. Urol., 135: 157A, Abstract #216, 1986.
    6. R. Shabsigh*, I.J. Fishman & F.B. Scott: Diagnosis of erectile impotence. German Urological Congress Annual Mtg., Bremerhaven, Germany, 1986.
    7. R. Shabsigh*, I.J. Fishman & F.B. Scott: Therapy of erectile impotence. German Urological Congress Annual Mtg., Bremerhaven, Germany, 1986.
    8. I.J. Fishman, R. Shabsigh & F.B. Scott: Experience with the artificial urinary sphincter AS-800 in 148 patients. J. Urol., 137: 232A, Abstract #514, 1987.
    9. R.M. Decter, D.R. Roth, I.J. Fishman, R. Shabsigh, F.B. Scott & E.T. Gonzales: the use of AS-800 in extrophy-epispadias. J. Urol., 139, 1988.
    10. R. Shabsigh*, I.J. Fishman, E.T. Quesada & C. Seale-Hawkins: Evaluation of vasculogenic erectile impotence using duplex ultrasonography. J. Urol., 139, 1989.
    11. R. Shabsigh*, S. St.C. Carter, S. Egawa, J.D. Wright, C.E. Carlton, Jr., & P.T. Scardino: Transrectal ultrasound and/or digitally guided biopsy of the prostate. J. Urol., 141: 282A, Abstract #449, 1989.
    12. R. Shabsigh*, M.J. Gleeson & I.J. Fishman: Penile vascular evaluation in diabetic and non-diabetic patients presenting with impotence; a comparative study. Texas Urological Society Annual Mtg., El Paso, TX, 1989.
    13. R. Shabsigh*, I.J. Fishman, B.D. Toombs & M. Skolkin: Venous leaks: anatomic and physiologic observations. J. Urol., 143: 302A, Abstract A#456, 1990.
    14. H.M. Landa, R. Shabsigh, D.R. Roth & E.T. Gonzales: Continent diversion in children. J. Urol., 143: 400A, Abstract #845, 1990.
    15. E.T. Quesada, R. Shabsigh, I.J. Fishman & F.B. Scott: Management of Peyronie's disease with the inflatable penile prosthesis: 190 cases. J. Urol., 145: 238A, Abstract #102, 1991.
    16. H.P. Koo, R. Buttyan, S.A. Kaplan, C.A. Olsson & R. Shabsigh*: Molecular changes in the penis of diabetic rats. AUA, NY-section Annual Mtg., Scottsdale, AZ, 1991.
    17. H.P. Koo, R. Buttyan, S.A. Kaplan, C.A. Olsson & R. Shabsigh: Molecular response in the bladder to the induction of diabetes in the rat. AUA, NY-section Annual mtg., Scottsdale, AZ, 1991.
    18. R. Shabsigh*, A.E. Te, H.P. Koo, S.A. Kaplan, C.A. Olsson & R. Buttyan: Localization of nerve growth factor beta (NGF) in the rat penis by in-situ hybridization. Society for Basic Urologic Research, Fall Symposium, Rochester, MN, 1991.
    19. S. A. Kaplan, R. Shabsigh & J.G. Blaivas: The use of prostatic stents in the management of prostatism in geriatric men. Urodynamic Society Annual Mtg., 1992.
    20. A.E. Te, M. Colombel, H.P. Koo, S.A. Kaplan, R. Buttyan, C.A. Olsson & R. Shabsigh*: Castration-induced apoptosis in the rat penis. ACS Annual Mtg., Chicago, IL, 1992.
    21. S. A. Kaplan & R. Shabsigh: Endoscopic and ultrasound visualization of insertion of a prostatic stent. J. Urol., 147: 208A, Abstract #V-84, 1992.
    22. A.E. Te, R. Buttyan, L. Greene, S.A. Kaplan, H.P. Koo, R. Buttyan, C.A. Olsson & R. Shabsigh*: Abundant expression of nerve growth factor (NGF) in the rat penis, a developmental study. J. Urol., 147: 239A, Abstract #102, 1992.
    23. H.P. Koo, A.E. Te, R. Buttyan, L. Greene, S.A. Kaplan, R. Buttyan, C.A. Olsson & R. Shabsigh*: Neurotrophin expression in diabetic rat penis: a new insight into the pathogenesis of diabetic erectile dysfunction. J. Urol., 147: 240A, Abstract #108, 1992.
    24. R. Shabsigh, H.P. Koo, A.E. Te, S.A. Kaplan, R. Buttyan, C.A. Olsson: Expression of neurotrophins*: NGF, BDNF and CNTF in the rat penis. J. Urol., 147: 318A, Abstract #422, 1992.
    25. A.E. Te., R. Buttyan, H.P. Koo, R. Shabsigh, C.A. Olsson & S.A. Kaplan: Nerve growth factor in diabetic cystopathy. J. Urol., 147: 350A, Abstract #550, 1992.
    26. R. Shabsigh*, A. E. Te & H. Fisch: Cavernous electromyography as an indication of adequate smooth muscle relaxation during penile duplex ultrasonography. 5th World mtg. on Impotence. Milan, Italy, 1992.
    27. A.E. Te, R. Buttyan, H.P. Koo, L. Greene, S.A. Kaplan, C.A. Olsson & R. Shabsigh*: Neurotrophins in the rat penis. 5th World meeting on Impotence. Milan, Italy, 1992.
    28. R. Shabsigh*, A.E. Te, H. Fisch, I.S. Sawczuk & C.A. Olsson: Combined dynamic infusion cavernosometry and cavernosography (DICC) with single potential analysis of cavernous electromyography (SPACE). AUA NY section Annual Mtg., Berlin, Germany, 1992.
    29. A.E. Te, R. Buttyan, H.P. Koo, S.A. Kaplan, C.A. Olsson & R. Shabsigh*: Neurotrophic factors in the diabetic rat penis: an extended study. J. Urol., 149: 247A, Abstract #136, 1993.
    30. H.P. Koo, Richard P. Santarosa, R. Buttyan, R. Shabsigh, C.A. Olsson & S.A. Kaplan: Comparison of gene expression in streptozotocin induced diabetic cystopathy and osmotic diureses in rat bladder. J. Urol., 149: 267A, Abstract #213, 1993.
    31. R.P. Santarosa, A.E. Te, J.P. Koo, R. Buttyan, S.A. Kaplan, C.A. Olsson & R. Shabsigh: Androgen deprivation and apoptosis in the rat erectile tissue. J. Urol., 151: 494A, Abstract #1067,1994.
    32. R.P. Santarosa, A.E. Te, J. Raymond, M. Colombel, C.A. Olsson, R. Buttyan & R. Shabsigh*: Testosterone sensitivity of the erectile tissue of the rat penis to castration. World Meeting on Impotence. Singapore, 9/12-16, 94, ISIR, 1994.
    33. A. Kirsch, M. Miller, J. Connor, T. Hensle & R. Shabsigh*: Tunica albugenia patch grafts, comparison of laser welding versus suturing. World meeting on Impotence. Singapore, 9/12-16, 94, ISIR, 1994.
    34. A. Kirsch, M. Miller, J. Connor, T. Hensle & R. Shabsigh*: Tunica albugenia patch grafts, comparison of laser welding versus suturing. American Academy of Pediatrics. St. Louis, 11, ISIR, 1994.
    35. J. Raymond, R.P. Santarosa, Kathleen M. O'Toole, C.A. Olsson, R. Buttyan & R. Shabsigh*: In-situ localization in the rat penis of DNA synthesis induced by testosterone after castration. J. Urol., 153: 508A, Abstract #1120, 1995.
    36. A. Kirsch, M. Miller, R. Shabsigh, T. Hensle & J. Connor: Urologic reconstruction using the diod laser and human protein solder. J. Urol., 153: 52A, 1995.
    37. L. T. Klein, M. I. Miller, R. Buttyan, A. Raffo, M. Burchardt, G. deVries, C. A. Olsson & R. Shabsigh*: Apoptosis in the rat penis after denervation. J. Urol., 155: A, 1996.
    38. H. Padma-Nathan, R. Shabsigh, et al: Treatment of erectile dysfunction (impotence) by transurethral Alprostadil. J. Urol., 155: A, 1996.
    39. R.W. Lewis, C.B. Brendler, A.L. Burnett, R.G. Ferrigni, W.G.J. Hellstrom, H. Padma-Nathan, N. Romas, & R. Shabsigh: A comparison of transurethral alprostadil and alprostadil/prazosin combinations for the treatment of erectile dysfunction. J. Urol., 157: 181A, abstract # 703, 1997
    40. L. T. Klein, M. I. Miller, R. Buttyan, A. Raffo, M. Burchardt, G. deVries, C. A. Olsson & R. Shabsigh*: Elevation of vascular endothelial growth factor in the rat penis after denervation. J. Urol., 157: 355A, abstract # 1388, 1997.
    41. R.A. Constable, F.E. Govier, R.G. Ferrigi, K.T.McVary, R. Shabsigh*, K.J. Nemo, P.Y. Tam, & A.P. Spivak: Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J. Urol., 157: 364A, abstract # 1424, 1997
    42. R. Shabsigh*: Treatment of erectile dysfunction at the end of the millenium. Internat. J. Impot. Res., 9: S22, 1997.
    43. R. Shabsigh*, L. Klein, S. Seidma, S.A. Kaplan, J. Ritter, B. Lehrhoff: High incidence of depressive symptoms is associated with erectile dysfunction. Internat. J. Impot. Res., 1998.
    44. R. Shabsigh*: Efficacy of Sildenafil is not affected by etiology of erectile dysfunction. Internat. J. Impot. Res., 1998.
    45. R. Shabsigh*, A. Shabsigh, & S. Flanders: Covariates of sexual function and bother in the first 6 months of treatment of prostate cancer with hormonal therapy: results from the CAPSURE database. Internat. J. Impot. Res., 1998.
    46. R. Shabsigh*, H. Padma-Nathan, J. Kaufman, M. Gittelman, & I. Goldstein: Comparative results of efficacy and safety of intracavernous alprostadil alfadex and intraurethral alprostadil. Internat. J. Impot. Res., 1998.
    47. K. Cooper, D. Weiner, V. Staiman, M. Biddelman, S. Seidman, & R. Shabsigh*: Prevalence of sexual dysfunction, urinary symptoms, and depressive symptoms in partners of men with erectile dysfunction. J. Urol., 161, (4), suppl, 270A, abstract # 1044, 1999.
    48. M. Burchardt, T. Burchardt, MW. Chen, A. Shabsigh, A. de La Taille, R. Buttyan, & R. Shabsigh*: Expression of RNA splice variants for VEGF in the adult rat and human penis. J. Urol., 161, (4), suppl, 219A, abstract # 840, 1999.
    49.  T. Burchardt, M. Burchardt, L. Baer, R. Pawar, A. Shabsigh, A. de La Taille, O. Hayek, M. Ghafar, & R. Shabsigh*: Sexual dysfunction in female patients with hypertension. J. Urol., 163, (4), suppl, 240A, abstract # 1068, 2000.
    50. H. Padma-Nathan, R. Shabsigh*, R. Weiss, DD. Michie, & R. Rosen: Efficacy and safety of alprostadil (Caverject) in Sildenafil (Viagra) failures. J. Urol., 163, (4), suppl, 201A, abstract # 895, 2000.
    51. AG Anastasiadis, AR Davis, M Fleming, L Cushman, D Barsbay, MA Ghafar, IS Sawzcuk, D Droggin, M Burchardt, R Shabsigh: Sexual Functioning among men and women with renal cancer. FSFF, 2001.
    52. H Padma-Nathan, RC Rosen, R Shabsigh, K Saikali, & V Watkins: Cialis (IC351) provides prompt response and extended period of responsiveness for the treatment of men with ED. J. Urol., 165 (5), suppl, 224A, abstract# 923, 2001.
    53. T. Burchardt, M. Burchardt, R Buttyan, A. Shabsigh, A. de La Taille, A Anastasiadis, MA Ghafar, & , R Shabsigh: Reduction in endothelial and smooth muscle density in the corpora cavernosa of the diabetic rat. J. Urol., 165 (5), suppl, 229A, abstract# 945, 2001.
    54. A Anastasiadis, H El-Rashidy, D Droggin, MP Rosenwasser, R Shabsigh & MC Benson: Sural nerve grafts with radical prostatectomy or radical cystectomy. J. Urol., 165 (5), suppl, 229A, abstract# 945, 2001.
    55. R. Shabsigh, JM Kaufman, C. Steidle, & H. Padma-Nathan: Testosterone replacement therapy with testosterone gel 1% converts Sildenafil non-responders to responders in men with hypogonadism and ED who failed prior Sildenafil alone. J. Urol., 169 (4), suppl, 247, abstract # 954.
    56. M. Burchardt, T. Burchardt, R. Buttyan, AG Anastasiadis, A. De La Taille, A. Shabsigh & R. Shabsigh: Angiogenic factors for therapy of ED: protein and DNA transfer of VEGF in the rat penis. J. Urol., 169 (4), suppl, 247, abstract # 1202.
    57. R Shabsigh, C Brown, JS Fendl, & J Yeager: Treatment of female sexual arousal disorder (FSAD) using a novel topical alprostadil cream, phase 2 clinical study. J. Urol., 169 (4), suppl, 247, abstract # 1322.
    58. AG Anastasiadis, R Sachdev, L Salomon, MA Ghafar, R Shabsigh & AE Katz: Quality of life after primary or salvage cryotherapy for clinically localized prostate cancer. J. Urol., 169 (4), suppl, 247, abstract # PD23.

Hobbies & special interests:

  • Hiking. 
  • Photography 

Languages:

  • English.
  • Arabic
  • Circassian
  • German
  • Spanish

<< click to view all presentations